XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Outstanding Stock Options

Total outstanding stock options as of September 30, 2023 was as follows:

 

 

Number of
shares

 

 

Weighted
average
exercise price

 

Outstanding at January 1, 2023

 

 

8,032,902

 

 

$

14.38

 

Granted

 

 

2,306,940

 

 

$

11.73

 

Exercised

 

 

(17,450

)

 

$

2.65

 

Cancelled or forfeited

 

 

(234,801

)

 

$

14.99

 

Outstanding at September 30, 2023

 

 

10,087,591

 

 

$

13.78

 

Schedule of Fair Value of Stock Options Determined on Grant Date Using Black Scholes Option-Pricing Model

The fair value of stock options, and the assumptions used in the Black Scholes option-pricing model to determine the grant date fair value of stock options granted to employees and non-employees were as follows, presented on a weighted average basis:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of stock options

 

$

7.77

 

 

$

8.45

 

 

$

8.31

 

 

$

9.40

 

Risk-free interest rate

 

 

4.36

%

 

 

2.89

%

 

 

3.71

%

 

 

2.09

%

Expected terms (in years)

 

 

6.08

 

 

 

6.08

 

 

 

6.01

 

 

 

5.98

 

Expected volatility

 

 

81.73

%

 

 

81.20

%

 

 

81.49

%

 

 

78.82

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Summary of Total Outstanding Restricted Stock Units

Total outstanding restricted share units as of September 30, 2023 was as follows:

 

 

Number of
shares

 

 

Weighted
average
grant date fair value

 

Outstanding at January 1, 2023

 

 

 

 

$

-

 

Awarded

 

 

626,260

 

 

$

12.42

 

Forfeited

 

 

(21,300

)

 

$

12.42

 

Outstanding at September 30, 2023

 

 

604,960

 

 

$

12.42

 

The fair value of each restricted share unit is estimated on the date of grant based on the fair value of our common shares on that same date.

Schedule of Share-based Compensation Expense

Share-based compensation expense was allocated as follows:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Research and development

 

$

3,339

 

 

$

2,600

 

 

$

9,887

 

 

$

7,351

 

General and administrative

 

 

3,038

 

 

 

2,453

 

 

 

8,817

 

 

 

7,202

 

Total share-based compensation expense

 

$

6,377

 

 

$

5,053

 

 

$

18,704

 

 

$

14,553

 

 

Share-based compensation expense by type of award was as follows:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Stock options

 

$

5,678

 

 

$

4,969

 

 

$

16,776

 

 

$

14,376

 

Restricted share units

 

 

625

 

 

 

 

 

 

1,670

 

 

 

 

ESPP

 

 

74

 

 

 

84

 

 

 

258

 

 

 

177

 

Total share-based compensation expense

 

$

6,377

 

 

$

5,053

 

 

$

18,704

 

 

$

14,553